Showing results (141-150 of 365) with videos related to

Sort By:
Pageof 37
Planta|November 12, 2013
Comparative biochemical and immunological studies of the glycine betaine synthesis pathway in diverse families of dicotyledonsE A Weretilnyk, S Bednarek, K F McCue, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2011
Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancerAmy J Davidoff, James F Gardner, Brian Seal, et al.
The Annals of Thoracic Surgery|May 1, 1996
Multimodality therapy in stage III non-small cell lung cancerM J Edelman, D R Gandara, M Roach, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims dataJosephine Feliciano, Lisa Gardner, Franklin Hendrick, et al.
Forensic Science International|March 26, 2018
Visual characteristics for sequencing of overlapping bloodstain patternsL J van Steijn, J C M Limborgh, G J Edelman
Plant Physiology|May 12, 2000
Radiotracer and computer modeling evidence that phospho-base methylation is the main route of choline synthesis in tobaccoS D McNeil, M L Nuccio, D Rhodes, et al.
Clinical Therapeutics|July 1, 1996
Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertensionS Oparil, E Barr, M Elkins, et al.
The Journal of Rheumatology|December 1, 1984
A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritisR N Thompson, C Watts, J Edelman, et al.
Clinical Lung Cancer|September 27, 2025
An Institution-Specific Hypofractionated Radiation Therapy Regimen in the Treatment of Central and Ultracentral Non-small Cell Lung CancerM Judy Lubas, Albi Vata, Jordan Fredette, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
Pageof 37